MRSHMarsh McLennan

$175.71-9.1% 1Y

Is the price fair?

Good

Cheap against its own history. That is the only one of 3 checks this filer's data supports, so take it as a single data point rather than a settled answer.

1 good, 2 without data
Vs its own P/E rangecheaper than 80% of its own historyderived

Cheap vs its own history: P/E 21.5 vs a 24.8 median over 41 quarters (−13% vs median).

Against the whole market›

Percentile against every name Ryufin tracks. Higher is better; the tick marks the middle of the market. Context, not one of the checks above.

P/E (valuation)middle of the market

Where this answer is blind. The growth-implied estimate assumes a fixed discount rate; capital-heavy sectors look structurally rich on it.

What MRSH's price assumes

Marsh McLennan trades at 21.5× earnings against 27.9× for the median Insurance Brokers name, cheaper than its own group.

21.5

Trailing P/E · Insurance Brokers median 27.9 · cheaper than the typical name in its group

Price / sales
2.86

Price / sales · as of 2026-Q2

Price / book
5.18

Price / book · as of 2026-Q2

EV / sales
3.54

EV / sales

Details›
Price / bookas of 2026-Q2
5.18
EV / EBITas of 2026-Q2
16.4
EV / salesas of 2026-Q2
3.54
Financial Services median P/E625 names
12.1
Insurance Brokers median P/E15 names
27.9
Market capitalisation
$78.2B
What the market has paid for these earnings: 41 quarters of its own multiple × $8.18 of trailing earnings per share
MethodPer share
Its own P/E history, lower quartile$179.67
Its own P/E history, median$202.78
Its own P/E history, upper quartile$215.86
52-week range$157.32 – $204.92
Today$175.71

Multiples from SEC filings and end-of-day closes; implied growth from a reverse discounted cash flow. Group medians across the names Ryufin tracks.